Senzime signs distribution agreement for the Swiss market
Uppsala, September 18, 2017. Senzime AB (publ) today announced an exclusive distribution agreement with Leuag AG regarding the Swiss market.Senzime has entered an exclusive distribution agreement with Leuag AG to enable the commercialization of the TetraGraph anesthesia monitoring system on the Swiss market. Leuag is a leading supplier of global medical brands in the field of patient monitoring, diagnostics and imaging. Lena Söderström, Senzimes CEO, commented: "Leuag is a great partner for several reasons. They have a complementary product portfolio, the network and the experience